HomeIDRSF • OTCMKTS
add
Idorsia Ltd
Previous close
$2.10
Year range
$1.40 - $10.00
Market cap
359.22M CHF
Avg Volume
1.98K
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
| (CHF) | Sep 2023info | Y/Y change |
|---|---|---|
Revenue | 79.92M | 280.05% |
Operating expense | 68.31M | -50.85% |
Net income | 224.05M | 203.75% |
Net profit margin | 280.35 | 127.30% |
Earnings per share | -0.29 | 74.56% |
EBITDA | -45.79M | 77.34% |
Effective tax rate | 0.62% | — |
Balance Sheet
Total assets
Total liabilities
| (CHF) | Sep 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 266.13M | -61.98% |
Total assets | 653.12M | -36.27% |
Total liabilities | 1.48B | -5.34% |
Total equity | -831.00M | — |
Shares outstanding | 178.23M | — |
Price to book | -0.45 | — |
Return on assets | -22.34% | — |
Return on capital | -46.24% | — |
Cash Flow
Net change in cash
| (CHF) | Sep 2023info | Y/Y change |
|---|---|---|
Net income | 224.05M | 203.75% |
Cash from operations | -76.22M | 61.08% |
Cash from investing | 267.00M | 132.54% |
Cash from financing | -30.00M | -118.52% |
Net change in cash | 161.09M | 96.83% |
Free cash flow | 3.77M | 102.98% |
About
Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. Wikipedia
Founded
2017
Website
Employees
1,361
